Latest News about CTLT
Recent news which mentions CTLT
Earnings Scheduled For August 29, 2022
August 29, 2022
From Benzinga
Catalent, Pinduoduo And 3 Stocks To Watch Heading Into Monday
August 29, 2022
From Benzinga
Bitcoin Tumbles Below This Major Level Following Powell's Remarks; Here Are The Top Crypto Movers For Monday
August 29, 2022
From Benzinga
Catalent-Repligen Merger 'Seems Unlikely,' This Analyst Says
August 12, 2022
From Benzinga
Catalent's New Acquisition will Expand High-Potent Capabilities, Oral Manufacturing Capacity: Report
August 10, 2022
Tickers
CTLT
From Benzinga
Quant Ratings Updated on 75 Stocks
May 26, 2022
From InvestorPlace
80 Biggest Movers From Yesterday
May 04, 2022
From Benzinga
41 Stocks Moving In Tuesday's Mid-Day Session
May 03, 2022
From Benzinga
Why Erytech Pharma Are Shares Moving Higher Today
April 25, 2022
From Benzinga
24 Biggest Movers From Yesterday
April 13, 2022
From Benzinga
Markets Fall As Investors Weigh March CPI Report
April 12, 2022
From Benzinga
From Benzinga
From Benzinga
Got $5,000? These 3 Growth Stocks Are Trading Near Their 52-Week Lows
February 21, 2022
From Motley Fool
Executives Sell More Than $210M Of 5 Stocks
February 09, 2022
From Benzinga
From MarketWatch
The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program
February 01, 2022
From Benzinga
Catalent's Q2 Earnings Beat Street View, Lifts FY22 Guidance
February 01, 2022
Tickers
CTLT
From Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
From Benzinga
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.